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Abstract
In mice, certain proteins show a highly confined expression in specific muscle groups. Also, resting and exercise/
contraction-induced phosphorylation responses are higher in rat skeletal muscle with low mitochondrial content compared
to muscles with high mitochondrial content, possibly related to differential reactive oxygen species (ROS)-scavenging ability
or resting glycogen content. To evaluate these parameters in humans, biopsies from soleus, gastrocnemius and vastus
lateralis muscles were taken before and after a 45 min inclined (15%) walking exercise bout at 69% VO2max aimed at
simultaneously activating soleus and gastrocnemius in a comparable dynamic work-pattern. Hexokinase II and GLUT4 were
46–59% and 26–38% higher (p,0.05) in soleus compared to the two other muscles. The type I muscle fiber percentage was
highest in soleus and lowest in vastus lateralis. No differences were found in protein expression of signalling proteins (AMPK
subunits, eEF2, ERK1/2, TBC1D1 and 4), mitochondrial markers (F1 ATPase and COX1) or ROS-handling enzymes (SOD2 and
catalase). Gastrocnemius was less active than soleus measured as EMG signal and glycogen use yet gastrocnemius displayed
larger increases than soleus in phosphorylation of AMPK Thr172, eEF2 Thr56 and ERK 1/2 Thr202/Tyr204 when normalised to
the mean relative EMG-signal. In conclusion, proteins with muscle-group restricted expression in mice do not show this
pattern in human lower extremity muscle groups. Nonetheless the phosphorylation-response is greater for a number of
kinase signalling pathways in human gastrocnemius than soleus at a given activation-intensity. This may be due to the
combined subtle effects of a higher type I muscle fiber content and higher training status in soleus compared to
gastrocnemius muscle.
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Introduction
Endurance exercise represents an immense stress to the working
muscle due to the increased ATP demand used for ion-pumping
and force generation and increased production of potentially
harmful by-products such as reactive oxygen species (ROS). To
minimise the homeostatic disturbance, the working muscle adapts
acutely by a number of mechanisms directed at increasing energy
substrate uptake and/or turnover [1]. In addition, repeated
exercise bouts elicit changes in gene expression patterns that lead
to mitochondrial biogenesis and increased expression of ROS-
handling enzymes [1,2]. Protein phosphorylation is indisputably
the most studied mechanism for muscular signal transduction and
muscle contraction has been documented to elicit a plethora of
protein phophorylation events to elicit adaptations to exercise [3].
Rodent muscles have been used extensively to identify and
characterise the ever-expanding kinase signalling networks acti-
vated by muscle contraction. Conceptually, muscles are often
divided into slow-twitch (type I) and fast-twitch (type II) fibers
dictated by their myosin heavy chain (MHC) isoform expression
[4]. Human muscle groups are mostly a homogenous mix of slow
and fast-twitch fibers whereas rodent muscle groups exhibit a more
extreme division into either type I or type II fiber-dominated
muscles [5–10].
In both rodents and humans, many endurance-training
responsive proteins are expressed in an activity-pattern dependent
manner, including glucose-handling proteins and mitochondrial
markers [1]. However, in mice in particular, there are clearly also
a number of proteins with expression confined to certain muscle
groups. For instance, the gamma3 subunit of contraction-activated
59-AMP-activated protein kinase (AMPK) and its downstream
substrate protein, TBC1D1, is lowly expressed in mouse slow-
twitch oxidative soleus compared to more fast-twitch glycolytic
muscles [11–14]. Although MHC isoform-distribution is more
mixed in humans than rodents, the expression of other potential
muscle group-specific proteins may be controlled by distinct
transcriptional regulators [4]. It is currently unknown whether any
of the muscle group-restricted proteins in mice are enriched in
certain muscle-groups in humans.
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in situ contraction-induced phosphorylation of a number of
kinases correlates inversely with the mitochondrial content of
different parts of the tibialis anterior muscle [15]. This might relate
to higher ROS-production per mitochondria in less oxidative
muscle [16,17]. To our knowledge, no study has attempted to
compare basal and exercise-stimulated kinase phosphorylation in
different human muscle-groups at a comparable work-load.
Here, the expression of selected proteins, some of which show
muscle group-confined expression in mice, was evaluated in
human soleus, lateral gastrocnemius and vastus lateralis-part (VL)
of the quadriceps femoris muscle. Furthermore, a human inclined
walking exercise model was employed with the aim of comparing
resting and exercise-induced kinase responses in human soleus and
gastrocnemius muscle at a comparable level of activation.
Results
A schematic overview of the experimental protocol is shown in
figure 1. All subjects completed a 15% inclined 45 min uphill
walking bout covering a mean distance of 4770 m and
corresponding to a 715 m elevation. This elicited a mean oxygen
uptake of 69.161.6 %VO2 max and changes in various blood
metabolites and hormones typical of whole-body exercise at this
intensity including increased lactate and catecholamines and lower
insulin (table 1).
The measured fibertype-distribution in the biopsies obtained
from human soleus, gastrocnemius and VL showed a roughly 20%
higher mean type I fiber content and equally lower type IIa fiber
content in soleus compared to gastrocnemius and VL (figure 2A).
Figure 2B and table 2 also show representative blots and lists the
total protein measurements performed on the current biopsy-
material. HXII content was higher in soleus compared to
gastrocnemius (p,0.01) and VL (p,0.001) and GLUT4 content
higher in soleus compared to gastrocnemius (p,0.05). In addition,
a strong trend towards a differential expression of the mitochon-
drial superoxide-converting enzyme, SOD2 was found (p=0.07
by 1-way ANOVA). All remaining proteins measured, including
signalling proteins (AMPK subunits, ERK, eEF2, TBC1D1,
TBC1D4), mitochondrial markers (F1 ATPase, COXI) and the
hydrogen peroxide-inactivating Catalase-enzyme showed no
significant differences in relative expression between muscles. A
much used loading control, actin, tended to be higher in soleus
compared to gastrocnemius (mean 28% lower) and VL (mean 7%
lower). Given that the quantifications for multiple proteins in these
samples and coomassie-staining indicates equal protein loading,
this may suggest that actin is a poor loading control for
comparison between muscles. Overall, the mouse pattern of high
enrichment of certain proteins within specific muscle groups is
unlikely to be present in humans.
Soleus was significantly more active than gastrocnemius
measured as both %EMGmax (Fig. 3A) and glycogen use
(Fig. 3B). Total glycogen tended to be higher in gastrocnemius
compared to soleus muscle although this was not significant
(Fig. 3B). VL was only minimally activated by the current exercise
regimen. Measured as %total glycogen use, the numbers were
70%, 57% and 2% for soleus, gastrocnemius and VL-muscle,
respectively.
ERK, AMPK and eEF2 phosphorylation were all significantly
higher after exercise in soleus and gastrocnemius, but not in VL
(Fig. 3C–E). Interestingly, despite the fact that gastrocnemius was
less active than soleus, the absolute mean activation after exercise
tended to be greater in gastrocnemius than soleus for all signalling
outcomes measured. When normalised to %EMGmax, gastrocne-
mius showed a significantly higher general kinase-responsiveness
to exercise compared to soleus (Fig. 3F, p,0.001, representative
blots in Fig. 3G).
Discussion
This study examined protein expression and kinase-signalling in
3 different muscle-groups of the lower extremity in humans. Our
first aim was to assess whether signalling proteins like AMPK and
TBC1D1 and 4, previously found to display muscle-group specific
Figure 1. Overview of experimental protocol for pre-test day and experimental days 1 and 2.
doi:10.1371/journal.pone.0031054.g001
Table 1. Blood parameters measured as indicated at various
time-points during an inclined walking exercise-bout at ,70%
VO2max.
Parameter Rest 15 min. 30 min. 45 min.
Glucose (mM) 5.1360.19 5.6560.18 6.0360.34* 6.3560.43*
Lactate (mM) 0.9360.1 3.5260.49* 3.8760.38* 3.9960.56*
Free fatty acids (mM) 5586106 320640* 379644 453668
Insulin (mU/ml) 3.5560.54 2.7660.52 1.7760.24** 1.4760.24***
Epinephrine (nM) 0.7660.07 1.6160.16 2.0760.21 2.3660.24
Norepinephrine (nM) 3.1460.8 16.3663.16 21.3462.25 20.7263.14
n=10.
*/**/***p,0.05/0.01/0.001 vs. corresponding resting value.
doi:10.1371/journal.pone.0031054.t001
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was clearly not the case and in general protein expression was
found to be similar in different lower extremity human muscles.
The second aim was to examine whether resting and exercise-
stimulated kinase-signalling differed between human muscles at a
given rate of activation as previously shown in rats. Surprisingly,
despite comparable expression of mitochondrial marker proteins,
glycogen content and only a trend towards lower SOD2 content in
gastrocnemius, the latter muscle displayed a ,60% greater mean
exercise-induced increase in phosphorylation-response for the 3
kinase-signalling pathways measured compared to soleus at a given
level of EMG-defined muscle activation.
A number of endurance-training responsive proteins have
previously been measured in distinct human muscle groups,
including GLUT4 and various markers of mitochondrial content
[6,7,21–23]. In general, our results of only subtle differences
between muscle groups are in agreement with these studies. This
implies that protein expression in human vastus lateralis, the most
commonly studied muscle in human exercise-studies, is likely to be
generally representative of other muscle groups. The most
differentially expressed protein in our study, HXII showed 46–
58% higher expression in soleus compared to other muscles. HXII
expression is often observed to be very sensitive to endurance-
training in humans [24], and the elevated HXII content in soleus
is probably reflective of its function as a postural muscle. Of note,
some of our total protein measurements (Catalase, COXI,
GLUT4, SOD2) show a tendency towards a ,20% lower level
in vastus lateralis compared to the other muscles. Based on the
mean standard deviation for these four proteins, a minimum
sample size of 17 would be needed to detect differences of this
magnitude at the a=0.05 level by western blotting in future
studies. However, even if our sample size is insufficient, the
differences between muscle groups for most proteins examined
seem to be small (,20%).
During preparation of this manuscript, a study was published
measuring selected proteins including TBC1D1 and TBC1D4 in
12 different rat muscles [25]. Similar to humans, TBC1D4
expression was not different and TBC1D1 expression showed a
,30% difference in expression range between different hindlimb-
muscles. This is in stark contrast to the muscle-type confined
expression in mice where TBC1D4 is enriched in slow-oxidative
muscle and TBC1D1 in fast-twitch glycolytic muscle [12]. Based
Figure 2. Characterisation of protein expression in different human muscle groups. A) Mean fibertype distribution and B) representative
blots of relative protein expression in human soleus (S), lateral gastrocnemius (G) and vastus lateralis (VL) as indicated. ** p,0.01 fibertype-difference
soleus vs. VL. n=7–8 for fibertype-determinations and n=10 for western blotting.
doi:10.1371/journal.pone.0031054.g002
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expression. Since transgenic mice are a major tool used to chart
signalling pathways in muscle-research, this obviously calls for
caution when generalising signalling concepts from mice to
humans or even other rodent species like rats.
Studies by David Hood’s group showed that mitochondrial
content was inversely correlated with the resting and in situ
contraction-stimulated phosphorylation of a number of kinases in
rat tibialis anterior muscle [15,16]. A putative causal link between
kinase phosphorylation and mitochondrial content might be
muscle group-specific differences in ROS-mediated signalling.
ROS is produced during exercise [2,26]. In the present study, the
lack of difference in SOD2 and catalase-expression did not support
that a poorer maintenance of redox-status in gastrocnemius
contributed to the higher kinase responsiveness in gastrocnemius
compared to soleus.
In rats and humans, low glycogen has been shown to correlate
with increased basal phosphorylation and/or exercise or insulin-
activation of some kinases including AMPK and Akt [27–29]. This
occurs by a poorly defined mechanism that does not appear to
involve increased skeletal muscle ROS-production in situations
with low glycogen in exercising humans [30]. In the present study,
the greater exercise-induced kinase-signalling response in gastroc-
nemius compared to soleus could not be explained by differences
in muscle glycogen which tended to be higher in gastrocnemius
than soleus muscle.
Endurance-training of rats or humans has been reported to
reduce phosphorylations in response to exercise of a number of
signalling proteins including AMPK, TBC1D4, mTOR, S6K1,
S6 and ERK at the same absolute work-intensity [31–35]
although the mechanism has not been resolved. Soleus is more
posturally active in daily life than gastrocnemius muscle and some
of our measured proteins, HXII and GLUT4, would suggest that
soleus has, as expected, been more habitually active than
gastrocnemius. Thus, it is tempting to ascribe the lower
activation-sensitivity in soleus vs. gastrocnemius to a training
effect in soleus vs. gastrocnemius in our study. While this
phenomenon could relate to an improved maintenance of cellular
energy charge for some kinases such as AMPK [34], this does not
explain why kinases with other activation-mechanisms would
behave similarly. Given that phosphatases can be reversibly
inactivated by ROS and affect kinase-activation [36] and the
previously discussed link between kinase-activation and mito-
chondrial ROS, we suspected that reactive oxygen species might
be involved. However, our data showing equal mitochondrial
enzymes and ROS-handling enzymes in soleus and gastrocne-
mius clearly do not support this hypothesis. Fascinatingly,
endurance-trained athletes have been reported to exhibit a much
higher phosphorylation of several proteins including AMPK, S6
and p38 MAPK than resistance trained athletes in response to
acute maximal isokinetic leg extension (resistance training)
exercise [37]. The opposite is also true in that strength-athletes
show a greater kinase-responsiveness than endurance-athletes for
some of the same kinases (AMPK, p38 MAPK) after 1 h of
moderate-high intensity cycling [37]. Since the greater kinase-
responsiveness of endurance-athletes to resistance exercise likely
occurs despite higher mitochondrial content and perhaps even a
higher percentage of type I fibers with lower intrinsic mitochon-
drial ROS production as suggested in rat [17], this again appears
to be more than a mere function of mitochondrial ROS
production. How this regimen-specific attenuation of kinase-
responsiveness by training is brought about will be an interesting
topic for future studies.
AMPK is an attractive drug target to treat insulin resistance
since its activation is likely sufficient to increase glucose uptake in
muscle cell culture and mouse muscle [38–40] and to drive
mitochondrial biogenesis [41]. AMPK is a heterotrimeric abc
protein-complex and some AMPK activators like AICAR and A-
769662 have been shown to require certain AMPK subunits to
elicit biological effects [11,13,42]. In rodent muscle, AMPK
subunit expression differs markedly between muscle groups as does
the expression of potential downstream effectors of contraction
and insulin-stimulated glucose uptake like TBC1D1 and 4 [11–
13,43]. We found near equal expression of these proteins in
different human muscle groups, implying that AMPK-dependent
signalling mechanisms are likely conserved between most human
skeletal muscles.
In conclusion, humans do not exhibit the extreme muscle-
specific expression of signalling proteins like AMPK and TBC1D1
and 4 seen in mice. Human gastrocnemius shows a greater
phosphorylation response of a number of kinases to exercise at a
given degree of EMG-verified activation than soleus. This
probably reflects a difference in training-status and muscle fiber
type composition between the muscles but occurs despite similar
expression of mitochondrial markers, ROS-handling enzymes and
glycogen content.
Methods
Subjects
10 young moderately trained male subjects [2662 yr,
18462 cm, 8562 kg, _ V VO2peak=5862m l ?(kg?min)
21] gave their
informed written consent to participate in the study, which was
approved by the Copenhagen Ethics Committee (reg. no. H-
KF277313) and conformed to the Helsinki II Declaration (1996).
Table 2. Relative protein expression quantified from western
blots in human soleus, lateral gastrocnemius (Gastroc.) and
lateral vastus of the vastus lateralis muscle (VL). SOD2 showed
a borderline significant trend (p=0.07, 1-way ANOVA).
Protein Soleus Gastroc. VL.
AMPK alpha1 1.0060.04 0.9860.11 0.9660.11
AMPK alpha2 1.0060.06 1.0060.08 1.0760.08
AMPK beta1 1.0060.15 0.8160.10 0.9460.12
AMPK beta2 1.0060.10 1.0560.14 1.1660.11
AMPK gamma3 1.0060.13 0.8760.10 1.1760.12
Catalase 1.0060.13 1.0260.20 0.8060.09
COXI 1.0060.12 0.9360.09 0.8160.08
eEF2 1.0060.14 0.9560.19 1.1060.21
ERK1/2 1.0060.07 1.1560.10 1.0960.05
F1 ATPase 1.0060.07 1.0160.08 0.8960.12
GLUT4 1.0060.16 0.6260.11* 0.7460.13
Hexokinase II 1.0060.15 0.5460.08** 0.4160.07***
SOD2 1.0060.08 0.9160.08 0.8060.07
TBC1D1 1.0060.15 0.9160.18 0.9760.19
TBC1D4 1.0060.06 1.1260.07 1.0760.14
Beta actin 1.0060.14 0.7260.13 0.9360.14
Coomassie 1.0060.11 0.9960.11 1.0160.10
n=10.
*/**/***p,0.05/0.01/0.001 vs. soleus.
doi:10.1371/journal.pone.0031054.t002
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Pre-test day. The subjects underwent one day of pre-testing
and 2 separate experimental days (see Figure 1 for graphic
overview). On the pre-test day, anthropometric measurements and
maximal oxygen uptake was determined in the fed condition.
Upon arrival, the subjects rested in the supine position for 15 min
after which resting pulmonary VO2 was determined. The subject
then undertook an inclined (15%) treadmill test at increasing
speeds to determine VO2max (starting at 6 km/h and increasing
1 km/h every minute until exhaustion) and calculate the
experimental walking speed. The 15% incline was shown in a
pilot experiment to activate both soleus and gastrocnemius muscle
measured as electromyography (EMG) signal during exercise (data
not shown).
Experimental day 1. On both experimental days the
subjects arrived in the morning after an overnight fast. On day
1, the subjects’ maximal voluntary EMG was determined for
soleus, gastrocnemius and vastus lateralis muscles, and
subsequently EMG was recorded with the same surface
electrodes during the experimental work-bout (15% incline,
walking speed corresponding to 65–70% VO2 max, for 45 min).
Relevant parts of a given subject’s legs were shaven,
sandpapered and wiped with ethanol after which electrodes were
placed in pairs approx. 2 cm. centre–to-centre above soleus,
gastrocnemius and vastus lateralis muscles in addition to a
reference electrode on the tibia. Maximal EMG responses (highest
of 3–5 attempts) were determined for soleus, gastrocnemius and
vastus lateralis during a maximal isometric knee extension, a
standing isometric loaded heel raise and a sitting isometric heel
raise with the knee at a 90u angle. The experimental bout started
approx. 90 min after arrival. During the experimental work-bouts,
EMG (sampling rate 1000 Hz) was recorded at 5–15 min, 20–
30 min and 35–45 min.
Experimental day 2. On day 2, a venous catheter was
inserted in the forearm antecubital vein for blood sampling. After
60 min of rest, 5 mm incisions were made for each biopsy (1/
muscle) above the soleus, lateral head of the gastrocnemius and the
vastus lateralis-part of the quadriceps muscles on both legs under
local anaesthesia (Xylocaine 2%, Astra-Zenica, Sweden). After an
additional 30 min, a resting blood sample and needle biopsy was
taken from each of the three muscles in one leg (randomised with
respect to dominant leg and biopsy-order), after which the
experimental work-bout was begun (15% incline, walking speed
corresponding to 65–70% VO2 max, 45 min). Blood samples were
collected at 15, 30 and 45 min. After completing the work bout,
biopsies were taken from the second non-biopsied leg, and divided
for histochemistry and biochemical analyses. The last biopsy was
frozen in liquid N2 within 3 min after work termination.
Pulmonary gas analysis
During the incremental maximal walking test, expired air was
collected in Douglas bags and analysed as previously described
[18].
EMG analysis
EMGmax was calculated as the largest 1 s root mean square
value obtained (average of ten 100-ms segments) during the
maximum contractions. EMG recorded during the walking
exercise was calculated as root mean square amplitudes (100 ms
segments) and expressed relative to the maximal EMG response
(% EMGmax). Resting EMG was subtracted from all values. No
differences were found between the three recording periods,
indicating no development of muscle fatigue. Therefore, data is
presented as average of the three periods recorded during the
work-bout.
Blood and plasma analyses
Plasma epinephrine, nor-epinephrine and insulin concentra-
tions were analysed by means of radioimmunoassay kits (High
sensitive 2-Cat RIA, Labor Diagnostika Nord GmbH & Co.,
Germany and Insulin RIA DSL-1600, Diagnostic Systems
Laboratories Inc., Webster, TX, USA). The plasma FFA
concentration and the blood concentration of glucose and lactate
were measured using an automatic analyzer (Hitachi automatic
analyzer 912; Boehringer Mannheim, Ingelheim, Germany).
Muscle fiber typing
Fibertype composition of the different muscles was determined
using histochemical ATPase staining of cryosections, as described
previously [19].
Muscle glycogen
Glycogen content was determined as glycosyl units after acid
hydrolysis of freeze dried dissected muscle biopsy specimens [19].
Muscle preparation
All materials were from Sigma-Aldrich (St. Louis, MO, USA)
unless stated otherwise. Freeze dried and dissected muscle biopsies
were homogenized 1:15 w/v using a Tissuelyser II (Qiagen, USA)
in ice-cold buffer containing 50 mM HEPES (pH 7.5), 150 mM
NaCl, 20 mM sodium pyrophosphate, 20 mM b-glycerophos-
phate, 10 mM NaF, 2 mM sodium orthovanadate, 2 mM EDTA,
1% NP-40, 10% glycerol, 2 mM PMSF, 1 mM MgCl2,1m M
CaCl2,1 0 mg/ml leupeptin, 10 mg/ml aprotinin, and 3 mM
benzamidine. Homogenates were rotated end over end for
30 min at 4uC and then cleared by centrifugation at 16.000 g at
4uC for 20 min. Protein content in the supernatant was measured
in triplicate by the bicinchoninic acid method, accepting a 5%
coefficient of variance (Pierce Rockford, IL). Then, the lysates
were diluted in Milli-Q ultrapure water and 66laemlii-buffer
(340 mM TRIS-base pH 6.8, 11% SDS, 20% glycerol, 0.05%
bromophenol blue and 225 mM freshly added DTT) to the same
protein concentration.
Immunoblotting procedures
Total protein and phosphorylation were measured by standard
immunoblotting techniques, largely as described previously [20].
For a given measurement, equal volumes and protein amounts of
all samples were separated by SDS-PAGE (PROTEAN Tetra,
BioRad, USA) using self-cast 15-well minigels (5–10% acrilamide,
5 gels per full sample set) cast from the same solution. Then,
regions of interest were identified based on the molecular weight
markers, cut from the gels and semidry-transferred (TE-77,
Amersham Biosciences, USA) onto the same PVDF-membrane
Figure 3. Exercise-induced signalling in different human muscle groups. Relative work-load during exercise-bout evaluated by A) % of
maximal EMG and B) glycogen content in human soleus (SOL), lateral gastrocnemius (Gast) and vastus lateralis (VL) before and after inclined walking
exercise at ,70% VO2max. Measured phosphorylations of C) ERK1/2, D) AMPK and E) eEF2 normalised per total protein in SOL, Gast and VL before
and after exercise. F) EMG-normalised phosphorylation per total protein in gastroc. vs. SOL. G) Representative blots. 1/111 p,0.05/0.001 vs. soleus.
*** p,0.001 exercise-effect vs. rest within muscle. {{{ p,0.001 muscle-effect, n=10.
doi:10.1371/journal.pone.0031054.g003
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and antibody-probing. If uneven transfer was suspected based on
the molecular weight markers or ECL signal obtained, the blots
were ponceau-stained to verify this and all samples rerun for the
measurement in question. Primary antibodies used were glucose
transporter 4 (GLUT4, Pierce, USA, cat#PA5-1065), hexokinase
II (HXII, Santa Cruz, USA, cat#28889), Cytochrome c oxidase I
(COXI, Invitrogen, USA, cat# 459600), F1 ATPase (Santa Cruz,
USA, cat#16689), SOD2 (Millipore, USA, cat#06-984), Catalase
(Abcam, USA, cat#52477), TBC1D1 (provided by C. MacKin-
tosh, University of Dundee, UK), TBC1D4 (Upstate, USA,
cat#07-741), alpha1, alpha2, beta1 and beta2 AMPK (provided
by D. G. Hardie, University of Dundee, UK), gamma3 AMPK
(Zymed, USA, cat#52-5717), eukaryotic elongation factor 2
(eEF2) total (Santa Cruz, USA, cat# 13004), extracellular receptor
activated protein kinase (ERK) 1/2 total (Cell Signaling
Technology, USA, cat#9102), pan-actin (Sigma, USA,
cat#A2668), phospho-ERK 1/2 Thr202/Tyr204 (Cell Signaling
Technology, cat#9101), phospho-Thr56 eEF2 (Cell Signaling
Technology, USA, cat#2331), phospho-Thr172 AMPK (Cell
Signaling Technology, USA, cat#2531). Horse-radish peroxidise-
conjugated secondary antibodies were from Dako (Glostrup,
Denmark). Band intensity was quantified by Kodak imaging
software (Kodak 1D version 3.5, USA). Loading was optimised for
signal and linearity for all antibodies prior to use. Coomassie-
staining after development was performed by submersion of PVDF
membranes for ,10 min in 0.5% Coomassie Blue G-250 in 50%
ethanol/10% acetic acid, removal of excess coomassie-stain with
distilled water followed by destaining in 50% ethanol/10% acetic
acid until bands were clearly visible. The strong band above
150 kDa was quantified. Half and double protein amounts were
loaded for one vastus lateralis sample to show that the signal was in
the dynamic range.
Statistics
Statistical evaluation was performed using SigmaPlot 11.0
(Systat Software Inc., USA) by 1-way ANOVA for protein
expression data (muscle), two-way ANOVA with repeated
measures (muscle6time) for rest vs. exercise, and one-way
ANOVA with repeated measures for blood data. When ANOVA
revealed significant differences, a Tukey’s post hoc test was used to
correct for multiple comparison. For the global comparison of
EMG-normalised data in Figure 3F, the normality-test failed and
the data-set was instead analysed using Wilcoxon’s signed rank
test. The significance level was set at p,0.05. All data are
expressed as mean 6 SEM.
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